Published in:
01-07-2019 | Prostate Cancer | Pelvis
68Ga-PSMA-11 PET/CT in newly diagnosed prostate cancer: diagnostic sensitivity and interobserver agreement
Authors:
Mohammad Abd Alkhalik Basha, Maged Abdel Galil Hamed, Omar Hussein, Tarek El-Diasty, Yasser Ibrahim Abdelkhalek, Yehia Omar Hussein, Ahmed Fathy Alasamer, Heba A. E. Mohamed, Dalia Salah El Deen, Engy Fathy Tantawy, Maha Ibrahim Metwally, Mohamed M. A. Zaitoun, Sameh Abdelaziz Aly, Jehan Ibrahim Altohamy, Abd El Motaleb Mohamed, Amira Hamed Mohamed Afifi, Ola Harb
Published in:
Abdominal Radiology
|
Issue 7/2019
Login to get access
Abstract
Purpose
To determine the diagnostic sensitivity and interobserver agreement of Gallium 68-prostate-specific membrane antigen positron emission tomography/computed tomography (68Ga-PSMA-11 PET/CT) imaging for diagnosis and staging of patients with newly diagnosed prostate cancer (PC).
Materials and methods
One hundred and seventy-three men (mean age, 68 ± 7.7 years; range 46–84 years) with newly diagnosed, untreated PC were enrolled in this prospective study between January 2017 and August 2018. All patients underwent a 68Ga-PSMA-11 PET/CT examination. For each patient, we determined the disease stage, the Gleason score, and the maximum standardized uptake value (SUVmax) for primary prostatic tumor and extraprostatic metastases. The diagnostic sensitivity and interobserver agreement of 68Ga-PSMA-11 PET/CT for diagnosis and staging of PC were established by histopathology as the reference standard.
Results
68Ga-PSMA-11 PET/CT examinations were interpreted as positive for PC in 166 of 173 patients (101 patients had primary prostatic tumor only, two patients had extraprostatic metastases only and 63 patients had combined lesions). The sensitivity of 68Ga-PSMA-11 PET/CT examination in the diagnosis of PC was 96%. 68Ga-PSMA-11 PET/CT produced a significant change of stage in 28.6% patients with an upstage in 17.9% patients and a downstage in 10.7% patients. The interobserver agreements were almost good to perfect (k = 0.63–0.89) for visual image interpretation, SUVmax measurement, and tumor staging.
Conclusion
68Ga-PSMA-11 PET/CT is a valuable tool with high diagnostic sensitivity (96%) and high reproducibility for diagnosis and staging of patients with newly diagnosed PC.